Spot on Doc, a very sticky product that already has credibility...

Spot on Doc, a very sticky product that already has credibility to become the gold standard in the biosample space. Only a matter of time until FOMO kicks in when a few more big companies incorporate BCT into their products and then others will get dragged along in the slipstream. 
The market is very slow catching on to the potential here, perhaps because it is not an OS company. Would be good to see more support for a great Aussie company, would hat to loose it.